Cover Image

Abscopal Effect After Localized Radiotherapy in a Patient With Sezary Syndrome Under Treatment with Mogamulizumab

Saved in:

Bibliographic Details
Main Authors:	Vieri Grandi (Author), Isabella Ciardetti (Author), Andrea Gemignani (Author), Eleonora Gherardi (Author), Tommaso Grassi (Author), Nicola Pimpinelli (Author)
Format:	Book
Published:	Mattioli1885, 2023-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Giant Primary Cutaneous Follicle Centre B-Cell Lymphoma
by: Alberto Corrà, et al.
Published: (2024)

The role of exosomes in tumour immunity under radiotherapy: eliciting abscopal effects?
by: Tianwen Yin, et al.
Published: (2021)

Cost-utility analysis of mogamulizumab in advanced mycosis fungoides and Sezary syndrome cutaneous T-cell lymphoma
by: Noemi Muszbek, et al.
Published: (2023)

The Need to Deepen the Abscopal Effect and Synergy among Radiotherapy and Immunotherapy
by: Denaro Nerina
Published: (2018)

Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome
by: Ilana D. Breen, BS, et al.
Published: (2021)

Alopecia areata after mogamulizumab treatment
by: Neel S. Raval, BS, MPHS, et al.
Published: (2022)

Skin-directed therapy and biologic response modifiers in mycosis fungoides
by: Vieri Grandi, et al.
Published: (2024)

Abscopal Effect of Local Irradiation Treatment for Diffuse Large B-cell Lymphoma
by: Yuri Hidaka, et al.
Published: (2017)

Bullous Kaposi Sarcoma: An Uncommon Blistering Variant in an HIV-Negative Patient
by: Eleonora Gherardi, et al.
Published: (2024)

An Asymptomatic Plaque on the Chest: A Quiz
by: Alessandro Pileri, et al.
Published: (2017)

Alopecia areata-like presentations with mogamulizumab therapy
by: Colin M. Kincaid, BS, et al.
Published: (2023)

Quantitatively immunological characterization of mogamulizumab skin disorders in ATL patients
by: Asahi Ito, et al.
Published: (2019)

Dupilumab-associated sezary syndrome
by: Austin Hamp, et al.
Published: (2023)

Alemtuzumab in refractory Sézary syndrome
by: Carmen María Alcántara Reifs, et al.
Published: (2016)

Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor
by: Carine M. Lama, MS, et al.
Published: (2023)

A case of mogamulizumab‐induced vitiligo in a patient with mycosis fungoides
by: Charissa N. Obeng‐Nyarko, et al.
Published: (2024)

Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
by: Nicholas A. Trum, BS, et al.
Published: (2021)

Understanding the Photodynamic Therapy Induced Bystander and Abscopal Effects: A Review
by: Kave Moloudi, et al.
Published: (2023)

Curcumin Enhances the Abscopal Effect in Mice with Colorectal Cancer by Acting as an Immunomodulator
by: Kuang-Chung Shih, et al.
Published: (2023)

Partial remission of advanced untreated Sézary syndrome after COVID-19
by: Caroline Snowden, BA, et al.
Published: (2022)

Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy
by: Xueying Wang, et al.
Published: (2024)

Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer
by: Bryan Oronsky MD, et al.
Published: (2018)

Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition
by: Maike Trommer, et al.
Published: (2019)

Corrigendum: Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition
by: Maike Trommer, et al.
Published: (2020)

Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario
by: José Antonio Sanches, et al.
Published: (2021)

Double-positive CD4 and CD8 Sézary syndrome
by: Denis Miyashiro, MD, et al.
Published: (2017)

Systemic treatments with monoclonal antibodies in mycosis fungoides and Sézary syndrome
by: Adalberto Ibatici, et al.
Published: (2024)

Dupilumab aggravates Sézary syndrome: The importance of accurate pathological diagnosis
by: Yoko Homma, et al.
Published: (2023)

Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
by: Hasina Maredia, MD, et al.
Published: (2021)

Effective treatment of mogamulizumab-induced head and neck dermatitis with fluconazole in a patient with peripheral E-cell lymphoma
by: Ishan Asokan, MD, MSc, et al.
Published: (2022)

Increased Serum Activin A Levels in Mycosis Fungoides and Sézary Syndrome
by: Tomonori Oka, et al.
Published: (2019)

A rare association of bullous pemphigoid with mycosis fungoides and Sézary syndrome
by: Andjela Egger, BS, et al.
Published: (2020)

Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases
by: Caitlin M. Brumfiel, MS, et al.
Published: (2020)

Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice
by: Jie Gao, et al.
Published: (2023)

Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update Micose fungóide e síndrome de Sézary: revisão e atualização clínica, histopatológica e imuno-histoquímica
by: Thamy Yamashita, et al.
Published: (2012)

Direct and Abscopal Antitumor Responses Elicited by AlPcNE-Mediated Photodynamic Therapy in a Murine Melanoma Model
by: José Athayde Vasconcelos Morais, et al.
Published: (2024)

Inducing the Abscopal Effect in Liver Cancer Treatment: The Impact of Microwave Ablation Power Levels and PD-1 Antibody Therapy
by: Changli Liao, et al.
Published: (2023)

Sezary syndrome, thyroid carcinoma, and renal carcinoma in a patient with Poland syndrome
by: Alexandra Kuzyk, MD, PhD, et al.
Published: (2022)

A Case of Sézary Syndrome in a Patient Treated with Dupilumab for Atopic Dermatitis
by: Kaito Muramatsu, et al.
Published: (2024)

Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab
by: Sarah A. Westergaard, MD, et al.
Published: (2020)